This company listing is no longer active
RADC.Q Stock Overview
Through its subsidiaries, operates a chain of retail drugstores in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Rite Aid Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.01 |
| 52 Week High | US$0.96 |
| 52 Week Low | US$0.0001 |
| Beta | 1.26 |
| 11 Month Change | 0% |
| 3 Month Change | -91.67% |
| 1 Year Change | -98.65% |
| 33 Year Change | -99.95% |
| 5 Year Change | -99.89% |
| Change since IPO | -99.93% |
Recent News & Updates
Recent updates
Rite Aid Shareholders Are Wiped Out Under A Chapter 11 Bankruptcy Plan
Oct 16Rite Aid May Be Forced Into Ch.11 Bankruptcy To Resolve Opioid Liabilities
Jul 10Rite Aid Q1 Earnings Preview: Bears Remain In Control
Jun 27Rite Aid names interim CEO as Heyward Donigan departs
Jan 09Rite Aid Q3 2023 Earnings Preview
Dec 20Rite Aid spikes 20% on above average volume
Nov 15Rite Aid partners with Google Cloud on pharmacy insights, customer engagement
Oct 11Shareholder Returns
| RADC.Q | US Consumer Retailing | US Market | |
|---|---|---|---|
| 7D | -60.0% | -1.9% | -2.2% |
| 1Y | -98.6% | 45.2% | 30.1% |
Return vs Industry: RADC.Q underperformed the US Consumer Retailing industry which returned 37% over the past year.
Return vs Market: RADC.Q underperformed the US Market which returned 22.7% over the past year.
Price Volatility
| RADC.Q volatility | |
|---|---|
| RADC.Q Average Weekly Movement | 611.9% |
| Consumer Retailing Industry Average Movement | 6.3% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in US Market | 15.6% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: RADC.Q's share price has been volatile over the past 3 months.
Volatility Over Time: RADC.Q's weekly volatility has increased from 314% to 612% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1962 | 47,000 | Jeffrey Stein | www.riteaid.com |
Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States. The company operates through two segments, Retail Pharmacy and Pharmacy Services. The Retail Pharmacy segment sells prescription drugs and provides various other pharmacy services and an assortment of products comprising over-the-counter medications, health and beauty aids, personal care products, seasonal merchandise, cosmetics, household items, food and beverages, greeting cards, seasonal and seasonal merchandise, pet care, and a variety of other everyday and convenience products, as well as brand and generic prescription drugs; and a private brand product line.
Rite Aid Corporation Fundamentals Summary
| RADC.Q fundamental statistics | |
|---|---|
| Market cap | US$2.19m |
| Earnings (TTM) | -US$1.64b |
| Revenue (TTM) | US$23.48b |
0.0x
P/S Ratio0.0x
P/E RatioIs RADC.Q overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| RADC.Q income statement (TTM) | |
|---|---|
| Revenue | US$23.48b |
| Cost of Revenue | US$18.75b |
| Gross Profit | US$4.73b |
| Other Expenses | US$6.36b |
| Earnings | -US$1.64b |
Last Reported Earnings
Sep 02, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -29.90 |
| Gross Margin | 20.14% |
| Net Profit Margin | -6.97% |
| Debt/Equity Ratio | -191.6% |
How did RADC.Q perform over the long term?
See historical performance and comparison